Firm Advises ARS Pharmaceuticals on IP Matters Related to $55 Million Series D
Firm Advises ARS Pharmaceuticals on IP Matters Related to $55 Million Series D
Client Highlights09/09/21
Life Sciences
Our Industry
Coverage
With one of the largest life sciences practices in the U.S., Wilson Sonsini’s industry legacy dates to the formative years of biotech and medical device. Working closely with scientists and entrepreneurs who grew their companies into thriving businesses, we have worked alongside to support their endeavors from whiteboard to clinical trial and beyond.
Industry Highlights
Celebrating our
founders’ successes
Life Sciences Industry
2013
NanoString Files IPO Worth $54 Million
Molecular Diagnostics2020
Lumos Pharma Sets Sights on SPAC
Drug Discovery2020
Oric Pharmaceuticals IPO Raises $120 Million
Drug Discovery2020
Applied Molecular Transport Closes IPO at $154 Million
Pharmaceuticals2020
ALX Oncology Prices IPO at $161 Million
Immuno-Oncology2020
HintMD is Acquired by Revance Therapeutics
Mobile Healthcare Platform2020
Athira Pharma Closes $204 Million IPO
Drug Discovery2020
PMV Pharmaceuticals Joins Nasdaq with $211 Million IPO
Drug Discovery2020
Artelo Biosciences Announces $6.6 Million Public Offering
Cannabinoid-Based Therapies2020
Seer IPO Raises $175 Million in Nasdaq Debut
Decision / Risk AnalysisAttorneys
focused
on this
industry
events
we organize
for you
10/07/21
UCSF Health Hub Awards
Wilson Sonsini is pleased to collaborate with UCSF Health Hub for the Health Awards to honor outstanding health technologies and innovations that are dramatically transforming healthcare, across 18 selected award categories including telehealth, remote and hospital diagnostics, patient cost savings and life sciences
Register now
